{
    "SPADE_UN_18858": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_18858",
            "Peptide Name": "LZ1 (Synthetic AMPs, Lys-rich, Trp-rich; UCLL1)",
            "Source": "designed based on a regulatory leucine zipper (LZ) domain of Heat shock factor 1",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "VKRWKKWWRKWKKWV",
            "Sequence Length": 15,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 2228.73,
            "PI": 12.0,
            "Hydrophobicity": -1.9,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Ran X, Burchfiel ET, Dong B, Rettko NJ, Dunyak BM, Shao H, Thiele DJ, Gestwicki JE. 2018",
                    "Reference": "Bioorg Med Chem. 2018 Oct 15;26(19):5299-5306. doi: 10.1016/j.bmc.2018.04.018.PubMed",
                    "Title": "Rational design and screening of peptide-based inhibitors of heat shock factor 1 (HSF1)."
                }
            ],
            "Frequent Amino Acids": "KWR",
            "Absent Amino Acids": "ACDEFGHILMNOPQSTUY",
            "Basic Residues": 8,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 7,
            "Polar Residues": 10,
            "Positive Residues": 8,
            "Negative Residues": 0,
            "Net Charge": 8,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (58.82%) toVV14K: 40%; W: 33%; R=V: 13%.Activity: Active against E. coli (MIC 31.0 ug/ml), P. aeruginosa (MIC 8.0 ug/ml), K. pneumonia (MIC 16.0 ug/ml), E. faecium (MIC 4.0 ug/ml), S. aureus (MIC 2.0 ug/ml), and C. acnes (MIC 8.0 ug/ml).",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_12597",
                    "Similarity": 1.0,
                    "Sequence": "RWKK"
                },
                {
                    "SPADE_ID": "SPADE_UN_03337",
                    "Similarity": 1.0,
                    "Sequence": "RWKKIWVIRWWR"
                },
                {
                    "SPADE_ID": "SPADE_UN_20247",
                    "Similarity": 1.0,
                    "Sequence": "RWKK"
                }
            ]
        }
    }
}